BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2022 10:06:45 AM | Browse: 341 | Download: 678
 |
Received |
|
2022-09-18 13:20 |
 |
Peer-Review Started |
|
2022-09-18 13:23 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-10-30 18:13 |
 |
Revised |
|
2022-11-05 09:23 |
 |
Second Decision |
|
2022-11-23 03:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-11-23 06:53 |
 |
Articles in Press |
|
2022-11-23 06:53 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2022-11-30 00:19 |
 |
Typeset the Manuscript |
|
2022-12-07 01:23 |
 |
Publish the Manuscript Online |
|
2022-12-27 10:06 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Vidyasagar Naik Bukke, Archana Moola, Gaetano Serviddio, Gianluigi Vendemiale and Francesco Bellanti |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Francesco Bellanti, MD, PhD, Associate Professor, Department of Medical and Surgical Sciences, University of Foggia, 1 Viale Pinto, Foggia 71122, Italy. francesco.bellanti@unifg.it |
Key Words |
Non-alcoholic fatty liver disease; Metabolic-associated fatty liver disease; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Antioxidants; Liver injury |
Core Tip |
This updated literature review contributes to the role of the nuclear factor erythroid 2-related factor 2 (NRF2) in combating inflammation, oxidative stress, steatosis, and fibrosis in metabolic associated fatty liver disease (MAFLD). There are several reviews that elucidate the advantages of NRF2 in human diseases, but this is the first review reporting the broad range of NRF2 modulators and their therapeutic implications in MAFLD. |
Publish Date |
2022-12-27 10:06 |
Citation |
Bukke VN, Moola A, Serviddio G, Vendemiale G, Bellanti F. Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease. World J Gastroenterol 2022; 28(48): 6909-6921 |
URL |
https://www.wjgnet.com/1007-9327/full/v28/i48/6909.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v28.i48.6909 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345